FOURKITES
16.11.2023 10:52:28 CET | Business Wire | Press release
FourKites today announces new additions to its senior leadership team to maximise customer value. Technology industry veteran Sean Fallon returns to FourKites as Chief Strategy Officer to drive strategy and support continued growth. Chief Product Officer Priya Rajagopalan takes on an expanded role that closely aligns customer operations and product development teams to maximise customer value. In addition, Mike DeAngelis (based in Denmark) joins as Head of International Solutions with a focus on ocean, having formerly worked at Maersk, WiseTech Global and project44.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231116700075/en/
FourKites appoints new executives to accelerate customer-driven innovation (Graphic: Business Wire)
FourKites’ 1,200 customers represent some of the largest and most complex supply chains in the world, and the platform touches over 50% of the Fortune 500. As global supply chains continue to grow in complexity, customers’ need for visibility beyond transportation has accelerated, and now requires end-to-end solutions that provide visibility into inventory, yards, warehouses, stores and beyond.
Gartner reflected this challenge in its 2023 Critical Capabilities for Real-Time Transportation Visibility Platforms report, and recognised FourKites as the top-scoring solution for the world’s most complex supply chains, specifically calling out the company’s “modal coverage and extended capabilities.” In addition, FourKites continues to garner accolades for its industry-leading innovation, most recently in FreightWaves’ FreightTech 25, which recognises the most innovative and disruptive companies in the freight technology sector. FourKites is the only visibility provider named to this year’s list — and together with Amazon Freight and J.B. Hunt, it is one of only three companies to appear on every list since 2018.
To support FourKites’ aggressive innovation agenda to provide maximum visibility for its customers, FourKites has expanded the scope of Chief Product Officer Priya Rajagopalan’s role to encompass customer operations, product and R&D. A seasoned business leader with over two decades of experience in product management, marketing and strategy, Rajagopalan has led FourKites’ Product team since 2016. She helped to build FourKites’ culture of customer-driven innovation, as many of FourKites’ platform capabilities have been developed in close collaboration with customers such as Land O’Lakes, Coca-Cola, Kimberly-Clark, Walmart Canada and others.
In addition, FourKites announced the return of Sean Fallon as Chief Strategy Officer to manage operational execution. Fallon is a seasoned technology executive and advisor, with extensive experience in private equity and venture-backed companies. With a focus on advancing enterprise software and SaaS businesses, he has led businesses through strategic liquidity events and M&A, including the sale of BigMachines to Oracle in 2013. Fallon served as President at FourKites from 2017 to 2021.
FourKites has also appointed Mike DeAngelis as Head of Ocean, where he will drive strategy and innovation around FourKites’ ocean solutions. A proven industry leader, DeAngelis served as General Manager and Head of Product Management at Maersk, Senior VP of global carrier strategy at WiseTech Global, and was most recently Senior Director of Growth, Ocean, at project44.
“We are excited to announce these appointments at a time when customers are looking for more opportunities for digitisation than ever before,” said Mathew Elenjickal, FourKites founder and CEO. “These additions bring a tight connection between the voice of the customer and our high-velocity R&D team, which will yield accelerated opportunities for innovation and customer value.”
These appointments come at a time of continued company growth as customers increasingly seek solutions beyond transportation visibility. Over the last year, FourKites has achieved a 28% increase in customers; 37% growth in its carrier network; and nearly 30% growth in shipment volume, across more than 220 countries and territories. The company sets the pace of innovation in the supply chain visibility market — most recently with Inbound Visibility, Appointment Manager, Fin AI (FourKites Intelligence Network) and My Workspace — as FourKites continues to expand its capabilities beyond transportation to provide customers with real-time insights that expedite decision-making throughout their end-to-end supply chain operations.
About FourKites
Leading global supply chain visibility platform FourKites® empowers business leaders with comprehensive visibility into transportation, yards, warehouses, stores and beyond. Tracking more than 3 million shipments daily across road, rail, ocean, air, parcel and last mile, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,200 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231116700075/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
